• ClipSaver
ClipSaver
Русские видео
  • Смешные видео
  • Приколы
  • Обзоры
  • Новости
  • Тесты
  • Спорт
  • Любовь
  • Музыка
  • Разное
Сейчас в тренде
  • Фейгин лайф
  • Три кота
  • Самвел адамян
  • А4 ютуб
  • скачать бит
  • гитара с нуля
Иностранные видео
  • Funny Babies
  • Funny Sports
  • Funny Animals
  • Funny Pranks
  • Funny Magic
  • Funny Vines
  • Funny Virals
  • Funny K-Pop
По дате По просмотрам Рейтинг
Последние добавленные видео:

Speaker:-Aaron-Gerds

  • Dr. Aaron Gerds - Bio VIdeo 8 лет назад

    Dr. Aaron Gerds - Bio VIdeo

    520 8 лет назад 1:56
  • An efficacy sub-analysis from the ACE-536-MF-001 study of luspatercept for MF-related anemia 1 год назад

    An efficacy sub-analysis from the ACE-536-MF-001 study of luspatercept for MF-related anemia

    76 1 год назад 3:19
  • Association between elevated WBC counts and thrombotic events in polycythemia vera 1 год назад

    Association between elevated WBC counts and thrombotic events in polycythemia vera

    425 1 год назад 3:44
  • Key highlights in MPNs: novel agents, combinations, and the potential role of immunotherapy 2 года назад

    Key highlights in MPNs: novel agents, combinations, and the potential role of immunotherapy

    330 2 года назад 13:31
  • Insights into the REVEAL trial: the efficacy of ruxolitinib for the treatment of patients with PV 2 года назад

    Insights into the REVEAL trial: the efficacy of ruxolitinib for the treatment of patients with PV

    80 2 года назад 1:27
  • Hematologists get social: medical microblogging on Twitter 5 лет назад

    Hematologists get social: medical microblogging on Twitter

    45 5 лет назад 3:56
  • Potential approval of pacritinib for the treatment of myelofibrosis 3 года назад

    Potential approval of pacritinib for the treatment of myelofibrosis

    308 3 года назад 1:15
  • Real-world use of fedratinib in patients with MF who have failed on ruxolitinib 1 год назад

    Real-world use of fedratinib in patients with MF who have failed on ruxolitinib

    124 1 год назад 1:27
  • Ruxolitinib in 2022: how this agent has transformed the MF treatment landscape 2 года назад

    Ruxolitinib in 2022: how this agent has transformed the MF treatment landscape

    133 2 года назад 2:07
  • ACE-536-MF-001 update: luspatercept for the treatment of anemia in myelofibrosis 1 год назад

    ACE-536-MF-001 update: luspatercept for the treatment of anemia in myelofibrosis

    301 1 год назад 2:26
  • The future of JAK inhibition for MPNs 10 месяцев назад

    The future of JAK inhibition for MPNs

    116 10 месяцев назад 1:26
  • Managing cytopenias following JAK inhibitor treatment & achieving true disease modification in MF 2 года назад

    Managing cytopenias following JAK inhibitor treatment & achieving true disease modification in MF

    115 2 года назад 1:22
  • Unmet needs and emerging options for patients with PV 2 года назад

    Unmet needs and emerging options for patients with PV

    47 2 года назад 1:15
  • Ruxolitinib’s place in the future treatment landscape for MPNs 3 года назад

    Ruxolitinib’s place in the future treatment landscape for MPNs

    68 3 года назад 1:43
  • Updated results from the MOMENTUM study assessing the efficacy of momelotinib in MF 2 года назад

    Updated results from the MOMENTUM study assessing the efficacy of momelotinib in MF

    126 2 года назад 1:24
  • Patient reported outcomes in myeloid malignancies 4 года назад

    Patient reported outcomes in myeloid malignancies

    29 4 года назад 1:44
  • Investigating the impact of pacritinib on survival in patients with MF and severe thrombocytopenia 1 год назад

    Investigating the impact of pacritinib on survival in patients with MF and severe thrombocytopenia

    128 1 год назад 2:28
  • Using RWD to evaluate the use of fedratinib as a potential bridge to HSCT in patients with MF 2 года назад

    Using RWD to evaluate the use of fedratinib as a potential bridge to HSCT in patients with MF

    61 2 года назад 1:16
  • How would the approval of luspatercept benefit the treatment landscape in myelofibrosis 10 месяцев назад

    How would the approval of luspatercept benefit the treatment landscape in myelofibrosis

    137 10 месяцев назад 1:46
  • Treating elderly, non-transplant eligible patients with MF 1 год назад

    Treating elderly, non-transplant eligible patients with MF

    152 1 год назад 1:56
Следующая страница»

Контактный email для правообладателей: [email protected] © 2017 - 2025

Отказ от ответственности - Disclaimer Правообладателям - DMCA Условия использования сайта - TOS



Карта сайта 1 Карта сайта 2 Карта сайта 3 Карта сайта 4 Карта сайта 5